[1]
Ayhan KAMANLI, “Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs”, Archives of Rheumatology, vol. 36, no. 1, pp. 001–009, Mar. 2021.